Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
Melbourne-based Pro Medicus Ltd (ASX:PME) shares were trading 5% higher on Thursday following the release of its financial report.
The Pro Medicus (ASX:PME) share price is up after announcing a new US deal with Nines.
Pro Medicus (ASX:PME) made an announcement this morning about it showcasing its Visage AI Accelerator.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.13% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.42% at lunch.
The Pro Medicus (ASX:PME) share price is rising after winning a new US-based long term contract.
The ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) went up 0.97% on Friday.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.16% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently down 0.62% at lunch.
